fascaplysine has been researched along with Astrocytoma, Grade IV in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Bryukhovetskiy, A; Bryukhovetskiy, I; Gulaia, V; Khotimchenko, R; Lyakhova, I; Piatkova, M; Romanishin, A; Sharma, A; Sharma, HS; Shmelev, M | 1 |
Bryukhovetskiy, A; Bryukhovetskiy, I; Kantemirov, A; Khotimchenko, R; Khotimchenko, Y; Lyakhova, I; Piatkova, M; Sharma, A; Sharma, HS; Zhidkov, M | 1 |
Bryukhovetsky, IS; Kantemirov, AV; Khotimchenko, YS; Kudryavtsev, IV; Lyakhova, IA; Zhidkov, ME | 1 |
1 review(s) available for fascaplysine and Astrocytoma, Grade IV
Article | Year |
---|---|
Alkaloids of fascaplysin are promising chemotherapeutic agents for the treatment of glioblastoma: Review.
Topics: Alkaloids; Antineoplastic Agents; Brain Neoplasms; Glioblastoma; Humans; Indoles | 2020 |
2 other study(ies) available for fascaplysine and Astrocytoma, Grade IV
Article | Year |
---|---|
3-Bromofascaplysin is a prospective chemical compound for developing new chemotherapy agents in glioblastoma treatment.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Indoles; Rats | 2020 |
Antitumor Activity of Fascaplysin Derivatives on Glioblastoma Model In Vitro.
Topics: Animals; Apoptosis; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Glioma; Indoles | 2018 |